Table 2 Resource use and unit costs
From: Competing treatments for migraine: a headache for decision-makers
Resource use item | Unit cost | Source |
|---|---|---|
Prophylactic drugs (3 monthly cycle) – 2022 prices | ||
BTAc | £276.40 | |
Eptinezumabc 100mg | £1,350.00 | |
Eptinezumabc 300mg | £4,050.00 | |
Fremanezumab—monthly | £1,350.00 | |
Fremanezumab—quarterly | £1,350.00 | |
Galcanezumab | £1,350.00a | |
Topiramate | £5.10 | |
Staff time in 2021/2022 prices | ||
Nurse (hourly cost) | £42.00 | Unit Costs of Health and Social Care, 2021 [35] |
Specialist consultant – neurologist (hourly cost) | £122.00b | Latest tariff did not include costs for neurology outpatient therefore assumed to be a Follow Up Attendance—Single Professional (WF01A) for a Neurology outpatient visits (code 400) [36] |
Other resource items in 2021/2022 prices | ||
GP visit | £39.23 | Unit Costs of Health and Social Care, 2021 [35] |
A&E visit | £165.00 | A&E worksheet. 'VB08Z', Emergency Medicine, Category 2 Investigation with Category 1 Treatment [37] |
Hospital admission | £618.00 | Non-elective tariff for code AA31E (Headache, Migraine or Cerebrospinal Fluid Leak, with CC Score 0–6) in worksheet “1 APC & OPROC” HRG code: AA31E [37] |
Triptan usage | £3.99 | The cost of triptans per attack was based on the weighted average of triptan costs in the UK, taken from NHS Prescriptions Cost Analysis [18, 25] |